Dean Investment Associates LLC Has $367,000 Stake in MetLife, Inc. (NYSE:MET)

Dean Investment Associates LLC decreased its position in shares of MetLife, Inc. (NYSE:MET) by 4.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,482 shares of the financial services provider’s stock after selling 220 shares during the quarter. Dean Investment Associates LLC’s holdings in MetLife were worth $367,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Sierra Ocean LLC bought a new position in shares of MetLife during the 4th quarter worth approximately $32,000. Retirement Wealth Solutions LLC bought a new position in MetLife during the 4th quarter valued at $32,000. Graney & King LLC purchased a new position in MetLife during the fourth quarter worth about $34,000. Values First Advisors Inc. bought a new position in shares of MetLife in the fourth quarter valued at approximately $36,000. Finally, Bank Julius Baer & Co. Ltd Zurich bought a new stake in shares of MetLife during the 4th quarter worth $48,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on MET. BMO Capital Markets began coverage on MetLife in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 target price for the company. Piper Sandler boosted their price target on shares of MetLife from $92.00 to $94.00 and gave the company an “overweight” rating in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods dropped their target price on shares of MetLife from $98.00 to $95.00 and set an “outperform” rating for the company in a research report on Wednesday, April 9th. Wells Fargo & Company decreased their price objective on MetLife from $97.00 to $91.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Finally, JPMorgan Chase & Co. reduced their price objective on MetLife from $88.00 to $86.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 2nd. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $92.46.

MetLife Stock Performance

MetLife stock opened at $72.49 on Friday. The stock’s 50 day simple moving average is $79.41 and its two-hundred day simple moving average is $82.19. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a market cap of $49.38 billion, a price-to-earnings ratio of 12.14, a PEG ratio of 0.65 and a beta of 0.89. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05.

MetLife (NYSE:MET) last released its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.